Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Case Report: Blunt Smoker Denies Tobacco Use, Delaying Diagnosis

Rachel E. Elam, MD, ScM, Vishal Arora, MD, & Alyce M. Oliver, PhD, MD  |  Issue: May 2022  |  May 12, 2022

Acro-osteolysis with resorptive changes of the tufts of the distal phalanges of (A) the left first, second and third digits, and (B) the right second and third digits.

Figure 1. Acro-osteolysis with resorptive changes of the tufts of the distal phalanges of (A) the left first, second and third digits, and (B) the right second and third digits.

No joint swelling or tendon rubs were present. No rashes or skin tightening at any other sites was seen. His anterior chest was sun damaged, with occasional telangiectasia. No other telangiectasia at any other location, including the oral mucosa or palms, was noted. The neurologic, cardiovascular, pulmonary and the remainder of the musculoskeletal examinations were unrevealing.

X-rays revealed acro-osteolysis of the distal phalanges of the affected fingers (see Figure 1).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The patient was started on oral vasodilators, nifedipine and sildenafil for the digital ulcerations. Intravenous antibiotics were also initiated for a superimposed cellulitis of the right second finger.

An orthopedic surgeon did not recommend surgical intervention on the right second digit for complicated soft tissue infection.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Arterial ultrasound showed no occlusive thrombus or stenosis of involved extremities. Transthoracic echocardiography excluded an intracardiac thrombus. The patient had a normal complete blood count, basic metabolic panel and coagulation profile. The hepatic function panel showed mild transaminase elevation (see Table 1). Laboratory testing, together with the history and exam, reasonably excluded autoimmune disease, hypercoagulable state and diabetes mellitus (see Table 1).

Computed tomography of the chest, abdomen and pelvis showed no evidence of vasculitis or pulmonary parenchymal disease, but atherosclerosis of the superior mesenteric and coronary arteries was seen. An invasive angiogram of both upper arms showed widely patent bilateral large vessels with severely diminished flow into the radial and ulnar arteries distally, with numerous corkscrew collateral arteries in the forearms (see Figure 2).

Table 1: Selected Laboratory Testing

Laboratory testPatient resultNormal values
Serum glucose (fasting)87 mg/dL74–106 mg/dL
Aspartate aminotransferase44 U/L11–35 U/L
Alanine transaminase57 U/L10–49 U/L
Erythrocyte sedimentation rate32 mm/hr0–26 mm/hr
C-reactive protein2.77 mg/dL0.0–0.5 mg/dL
Rheumatoid factor20.3 IU/mL0–14 IU/mL
C3138 mg/dL90–170 mg/dL
C441.6 mg/dL19–52 mg/dL
HIV screen1NonreactiveNonreactive
HBsAgNonreactiveNonreactive
HBsAbNonreactiveNonreactive
Hepatitis C antibodyReactiveNonreactive
Hepatitis C RNA VL264,657 IU/mL≤25 IU/mL
SARS-CoV-2 PCRNegativeNegative
Thyroid stimulating hormone2.70 mcIU/mL0.4–4.7 mcIU/mL
Calcium (serum)9.3 mg/dL8.7–10.4 mg/dL
Parathyroid hormone32.6 pg/mL11.1–79.5 pg/mL
Anti-nuclear antibody1:80, nucleolar pattern≤1:40
U1-RNP antibody<0.2 U<1.0 U
Smith antibody<0.2 U<1.0 U
dsDNA antibody<12.3 IU/mL<30.0 IU/mL
Scl-70 antibody<0.2 U<1.0 U
Centromere antibody<0.2 U<1.0 U
ANCA proteinase 3<0.2 U<0.4 U
ANCA myeloperoxidase<0.2 U<0.4 U
β-2-glycoprotein-1 IgG<9.4 U/mL<15.0 U/mL
β-2-glycoprotein-1 IgM<9.4 U/mL<15.0 U/mL
Cardiolipin IgG<9.4 MPL< 15.0 MPL
Cardiolipin IgM2<9.4 MPL<15.0 MPL
CryoglobulinsNegativeNegative
SPEP/SIFENo monoclonal IgNo monoclonal Ig
Key: HIV: Human immunodeficiency virus; HBsAg: Hepatitis B surface antigen; HBsAb: Hepatitis B surface antibody; RNA VL: Ribonucleic acid viral load; SARS-CoV-2 PCR: Severe acute respiratory syndrome coronavirus 2 polymerase chain reaction; U1-RNP: U1 ribonucleoprotein; dsDNA: Double stranded deoxyribonucleic acid; ANCA: Anti-neutrophil cytoplasmic antibody; Ig: Immunoglobulin; SPEP/SIFE: Serum protein electrophoresis/serum immunofixation
Notes
1 HIV antigen/antibody combination assay simultaneously detected HIV-1 p24 antigen, antibodies to HIV-1 (group M and O)—IgG and IgM, and antibodies to HIV-2—IgG and IgM.
2 Lupus anticoagulant was not obtained because the patient was receiving low-molecular weight heparin for deep venous thrombosis prophylaxis.

At this juncture, we explicitly questioned the patient on his mode of cannabis administration and discovered he was a daily blunt smoker.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Conditions Tagged with:cannabiscase reportmarijuanathromboangiitis obliteranstobacco

Related Articles

    Cannabis for Pain Relief: An Area Ripe for Research

    September 28, 2023

    Medical cannabis may benefit patients experiencing pain, and rheumatologists should be able to discuss its potential risks and benefits with their patients. Here are insights from Dr. Mary Ann Fitzcharles on current research, patient use and more.

    Cannabis in Rheumatology Care: A Look at the Latest Research & What Rheumatologists Are Telling Their Patients

    March 26, 2018

    As medical and recreational marijuana becomes more accessible, researchers seek creative ways to study the cannabis plant and explore the complexities of the endocannabinoid system in pain relief. Rheumatologists currently face an influx of patients asking if marijuana can help them. Here’s a look at the evolving research on cannabinoids for rheumatologic pain management and how doctors are discussing it with their patients…

    Cannabinoids Show Potential in Pain Management

    February 13, 2020

    ATLANTA—The potential of cannabis‐based medicines is a hot topic, particularly as pain management therapy for arthritis and other conditions. However, confusion abounds regarding its therapeutic potential, how it can be administered and even the correct terminology to use. David P. Finn, PhD, professor of pharma­cology and therapeutics, and founding co-director of the Centre for Pain…

    Marijuana for Rheumatology Patients?

    February 17, 2018

    SAN DIEGO—What does cannabis offer to the treatment and management of rheumatology patients and the range of pain states they experience? What do we really know about its long-term effects? These are hard questions to answer with currently available data and a reality nuanced by complications cannabis advocates don’t always recognize, according to two experts…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences